Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Inventory Average (2016 - 2025)

Historic Inventory Average for Tandem Diabetes Care (TNDM) over the last 12 years, with Q3 2025 value amounting to $139.9 million.

  • Tandem Diabetes Care's Inventory Average fell 1090.25% to $139.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.9 million, marking a year-over-year decrease of 1090.25%. This contributed to the annual value of $153.8 million for FY2024, which is 1430.75% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Inventory Average stood at $139.9 million, which was down 1090.25% from $141.9 million recorded in Q2 2025.
  • Tandem Diabetes Care's 5-year Inventory Average high stood at $157.8 million for Q2 2024, and its period low was $65.3 million during Q1 2021.
  • For the 5-year period, Tandem Diabetes Care's Inventory Average averaged around $117.6 million, with its median value being $139.6 million (2023).
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 6608.03% in 2023, then tumbled by 1090.25% in 2025.
  • Over the past 5 years, Tandem Diabetes Care's Inventory Average (Quarter) stood at $67.1 million in 2021, then soared by 60.77% to $107.9 million in 2022, then skyrocketed by 39.62% to $150.7 million in 2023, then grew by 0.21% to $151.0 million in 2024, then fell by 7.35% to $139.9 million in 2025.
  • Its Inventory Average stands at $139.9 million for Q3 2025, versus $141.9 million for Q2 2025 and $145.4 million for Q1 2025.